Risk-Stratified Venous Thromboembolism Chemoprophylaxis After Total Joint Arthroplasty: Evaluation of an Institutional Approach

被引:0
|
作者
Hyland, Sara J. [1 ,2 ]
Fada, Maria J. [2 ]
Secic, Michelle [3 ]
Fada, Robert A. [4 ]
Lockhart, Marie M. [5 ]
Parrish, Richard H. [6 ]
机构
[1] OhioHealth, Grant Med Ctr, Dept Pharm, Columbus, OH 43215 USA
[2] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA
[3] Sec Stat Consulting Inc, Cleveland Hts, OH 44106 USA
[4] OhioHealth Grant Med Ctr, Dept Orthoped, Columbus, OH 43215 USA
[5] OhioHealth Res Inst, Columbus, OH 43214 USA
[6] Mercer Univ, Sch Med, Columbus, GA 31901 USA
关键词
aspirin; chemoprophylaxis; postoperative complications; postoperative hemorrhage; risk stratification; total joint arthroplasty; venous thromboembolism; TOTAL HIP-ARTHROPLASTY; KNEE ARTHROPLASTY; PROPHYLAXIS; ASPIRIN; GUIDELINES; THROMBOPROPHYLAXIS; ANTICOAGULANTS; RIVAROXABAN;
D O I
10.3390/jcm14020366
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Objectives: The optimal venous thromboembolism (VTE) chemoprophylaxis approach after hip or knee total joint arthroplasty (TJA) remains controversial. This study aimed to characterize antithrombotic-related complications associated with various chemoprophylaxis regimens after TJA and to assess our current institutional risk-stratified prescribing tool. Methods: This retrospective case-control study and regression analysis included elective unilateral TJA patients at a single institution between 1 July 2015 and 31 December 2021. The primary outcome was a composite of antithrombotic-related complications within 30 days of surgery, including thrombotic and hemorrhagic/wound-related adverse events. The duration of anticoagulant chemoprophylaxis prescribed prior to aspirin monotherapy (0-28 days) was compared between patients who did vs. did not experience a complication, with stratification by institutionally defined VTE risk categories (Routine, Moderate, or High Risk). The complication rate was then assessed as a function of anticoagulant duration within each risk subgroup. Results: The study included 5420 patients, with 279 (5.2%) experiencing >= 1 complication. Routine VTE risk patients experienced few complications, with no significant difference between aspirin monotherapy and various initial anticoagulant durations (p = 0.6118). Moderate and High VTE Risk patients saw significantly lower complication rates with initial anticoagulant prophylaxis of increasing durations (p = 0.0090 and p = 0.0050), with a significant overall effect of VTE Risk strata observed (p = 0.0006). Conclusions: When both bleeding and thrombotic events are considered, anticoagulant-to-aspirin regimens were associated with lower complication rates than aspirin monotherapy in higher risk patients, while routine patients saw no significant benefit over aspirin. Our risk-stratified prescribing approach should be prospectively evaluated.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Risk-Stratified Venous Thromboembolism Prophylaxis After Total Joint Arthroplasty: Aspirin and Sequential Pneumatic Compression Devices vs Aggressive Chemoprophylaxis
    Odeh, Khalid
    Doran, James
    Yu, Stephen
    Bolz, Nicholas
    Bosco, Joseph
    Iorio, Richard
    JOURNAL OF ARTHROPLASTY, 2016, 31 (09): : S78 - S82
  • [2] Risk-Stratified Venous Thromboembolism Prophylaxis after Total Joint Arthroplasty: Low Molecular Weight Heparins and Sequential Aspirin vs Aggressive Chemoprophylaxis
    Peng, Hui-Ming
    Chen, Xi
    Wang, Yi-Ou
    Bian, Yan-Yan
    Feng, Bin
    Wang, Wei
    Weng, Xi-Sheng
    Qian, Wen-Wei
    ORTHOPAEDIC SURGERY, 2021, 13 (01) : 260 - 266
  • [3] Evaluation of simplified risk-stratified twice daily aspirin protocol for venous thromboembolism prophylaxis after total joint replacement
    Ng, Candy
    Zavala, Sarah
    Pinzur, Michael S.
    PHARMACOTHERAPY, 2017, 37 (12): : E177 - E177
  • [4] A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study
    Johnson, Stacy A.
    Jones, Aubrey E.
    Young, Elizabeth
    Jennings, Cassidy
    Simon, Kelsey
    Fleming, Ryan P.
    Witt, Daniel M.
    THROMBOSIS RESEARCH, 2021, 206 : 120 - 127
  • [5] Individualized Risk Model for Venous Thromboembolism After Total Joint Arthroplasty
    Parvizi, Javad
    Huang, Ronald
    Rezapoor, Maryam
    Bagheri, Behrad
    Maltenfort, Mitchell G.
    JOURNAL OF ARTHROPLASTY, 2016, 31 (09): : S180 - S186
  • [6] Venous Thromboembolism Prophylaxis After Total Joint Arthroplasty
    Flierl, Michael A.
    Messina, Michael J.
    Mitchell, Justin J.
    Hogan, Craig
    D'Ambrosia, Robert
    ORTHOPEDICS, 2015, 38 (04) : 252 - 263
  • [7] Clinical efficacy of risk-stratified prophylaxis with low-dose aspirin for the management of symptomatic venous thromboembolism after total hip arthroplasty
    Mihara, Masahiko
    Tamaki, Yasunobu
    Nakura, Nariaki
    Takayanagi, Satoshi
    Saito, Akira
    Ochiai, Shunsuke
    Hirakawa, Kazuo
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2020, 25 (01) : 156 - 160
  • [8] Early Response to Warfarin Initation and the Risk of Venous Thromboembolism After Total Joint Arthroplasty
    Edelstein, Adam, I
    Terzaghi, Clara
    Nudelman, Brandon
    Qin, Charles
    Kwasny, Mary
    Manning, David W.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2018, 26 (04) : E90 - E97
  • [9] The benefit of aspirin chemoprophylaxis for thromboembolism after total knee arthroplasty
    Lotke, Paul A.
    Lonner, Jess H.
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2006, (452) : 175 - 180
  • [10] Risk factors for venous thromboembolism after primary total joint arthroplasty: An analysis of 7511 Taiwanese patients
    Chang, Wei-Lin
    Pai, Fu-Yuan
    Tsai, Shang-Wen
    Chen, Cheng-Fong
    Wu, Po-Kuei
    Chen, Wei-Ming
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2024, 87 (05) : 498 - 504